Seroprevalence studies indicate that less than 10% of people in the U. S. have detectable antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from July to September 2020.
from News Medical Medical Research News Feed https://ift.tt/33wNoYP
0 Comments